Hussein A Assi (Hussein Assi)

Years Active: 2019-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Hussein A Assi, Adam S Asch, Michael Machiorlatti, Sara K Vesely, Sami Ibrahimi
Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy. Future science OA 6 (7) (2020)
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, Mehmet Asim Bilen, Victor Santos, John Esther, Rafael Morales-Barrera, Michael Devitt, Ariel Nelson, Christopher J Hoimes, Evan Shreck, Hussein A Assi, Benjamin A Gartrell, Alex Sankin, Alejo Rodriguez-Vida, Mark Lythgoe, David James Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah Hahn, Sandy Liu, Lucia Alonso Buznego, Ignacio Duran, Marcus Moses, Jayanshu Jain, Jure Murgic, Praneeth Baratam, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D Galsky, Guru Sonpavde, Evan Y Yu, Veena Shankaran, Gary H Lyman, Petros D Grivas
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Cancer 126 (6) (2019)
Hussein A Assi, Sarbajit Mukherjee, Pamela L Kunz, Michael Machiorlatti, Sara Vesely, Vipul Pareek, Hassan Hatoum
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database. The oncologist 25 (2) (2019)

Hussein A Assi.css-eqlu8i{font-size:small;padding-left:4px;} (Hussein Assi)